Access cutting-edge breast cancer treatment through this clinical trial at a research site in Golden. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Golden at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in combination with a CDK4/6 inhibitor.
Sponsor: Olema Pharmaceuticals, Inc.
Check if you qualify for this breast cancer clinical trial in Golden, CO
If you're searching for breast cancer treatment options in Golden, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Golden research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.